One Platform. Three Ways to Capture.
A single unified biosensor platform captures biological signals from patients & environments across three modalities.
Swab
Clinical Beachhead
Reimbursable point-of-care diagnostic; fastest path to FDA clearance and revenue.
Breath
Field & Mass Screening
Non-invasive, deployed for institutional and government mass screening contracts — Varro’s second diagnostic product via the De Novo pathway
Air
Real-Time Surveillance
Subscription-based monitoring contracts. Each deployed node feeds the population-scale data network.
Decisions are Still Made Without Continuous Biological Data
Varro Provides the Infrastructure Layer for Real-Time Biological Sensing
Exciting Things are Happening at Varro!
Varro Life Sciences is building momentum with the opening of its new St. Louis R&D facility. Backed by a $42.5 million investment and 33 new jobs, the company is accelerating its path toward breakthrough biosensor innovations and long-term growth.
For more coverage of the ribbon cutting ceremony, click here.
News and Updates
Get the Latest from Varro!
Fill out the form below and subscribe to our newsletter.
